Literature DB >> 17704932

Treatment of an acute salivary fistula after parotid surgery: botulinum toxin type A injection as primary treatment.

Young Chang Lim1, Eun Chang Choi.   

Abstract

A salivary fistula is a relatively uncommon but troublesome complication after parotid surgery. Most cases are self-limiting and respond well to conservative therapy (compression dressings). However, this treatment may require weeks before its effect becomes evident. We present the first report of direct administration of botulinum toxin type A as an effective primary treatment for an acute salivary fistula after parotid surgery, in the absence of other, more conservative treatment. A 47-year-old man with a 7-day history of sore throat was found to have a parapharyngeal tumor originating from the deep lobe of the parotid gland. He underwent tumor removal via a trans-paroticocervical approach. However, on postoperative day 7, the patient was noted to have massive salivary discharge from the surgical incision during a meal. We administered a transcutaneous botulinum toxin type A injection without a pressure dressing. One day after the injection, the salivary discharge from the incision line disappeared completely and there was no evidence of recurrent sialorrhea in the 6 months following the procedure. This report suggests that the injection of botulinum toxin type A is a highly effective and relatively safe primary method of treatment for an acute postparotidectomy salivary fistula, and not merely an alternative to more conservative therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17704932     DOI: 10.1007/s00405-007-0418-6

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  9 in total

1.  New prospects in the treatment of traumatic and postoperative parotid fistulas with type A botulinum toxin.

Authors:  Jens J von Lindern; Bernd Niederhagen; Thorsten Appel; Stefaan Bergé; Rudolf H Reich
Journal:  Plast Reconstr Surg       Date:  2002-06       Impact factor: 4.730

2.  Post-parotidectomy fistula.

Authors:  M Wax; L Tarshis
Journal:  J Otolaryngol       Date:  1991-02

3.  The therapeutic use of botulinum toxin.

Authors:  V Tugnoli; R Eleopra; C Montecucco; D De Grandis
Journal:  Expert Opin Investig Drugs       Date:  1997-10       Impact factor: 6.206

4.  Up-to-date report of botulinum toxin type A treatment in patients with gustatory sweating (Frey's syndrome).

Authors:  R Laskawi; C Drobik; C Schönebeck
Journal:  Laryngoscope       Date:  1998-03       Impact factor: 3.325

5.  Post-traumatic parotid fistulae and sialoceles. A prospective study of conservative management in 51 cases.

Authors:  D Parekh; G Glezerson; M Stewart; J Esser; H H Lawson
Journal:  Ann Surg       Date:  1989-01       Impact factor: 12.969

6.  The role of botulinum toxin in postparotidectomy fistula treatment. A technical note.

Authors:  Rosario Marchese-Ragona; Gino Marioni; Domenico A Restivo; Alberto Staffieri
Journal:  Am J Otolaryngol       Date:  2006 May-Jun       Impact factor: 1.808

7.  A pilot study evaluating the treatment of postparotidectomy sialoceles with botulinum toxin type A.

Authors:  H Vargas; L T Galati; S M Parnes
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2000-03

8.  Surgical management of pleomorphic adenomas of the parotid gland: a follow-up study of three methods.

Authors:  R Laskawi; T Schott; M Mirzaie-Petri; M Schroeder
Journal:  J Oral Maxillofac Surg       Date:  1996-10       Impact factor: 1.895

9.  Conservative management of post-traumatic parotid fistulae and sialoceles: a prospective study.

Authors:  R Landau; M Stewart
Journal:  Br J Surg       Date:  1985-01       Impact factor: 6.939

  9 in total
  15 in total

1.  The Effect of Botulinum Toxin on an Iatrogenic Sialo-Cutaneous Fistula.

Authors:  Seung Eun Hong; Jung Woo Kwon; So Ra Kang; Bo Young Park
Journal:  Arch Craniofac Surg       Date:  2016-12-23

2.  Primary treatment of early fistula of parotid duct with botulinum toxin type A injection.

Authors:  Camila Ferron; Selma Schuartz Cernea; Ada Regina Trindade de Almeida; Denise Vieira Galvão Cesar
Journal:  An Bras Dermatol       Date:  2017 Nov-Dec       Impact factor: 1.896

3.  Management of chronic parotid fistula with sodium tetradecyl sulfate.

Authors:  Virendra Singh; Pradeep Kumar; Aviral Agrawal
Journal:  J Oral Biol Craniofac Res       Date:  2013-01-09

4.  Hypertonic saline solution for management of parotid fistula: A case report.

Authors:  Ajaz A Shah; Nahida Dar; Mohammed Israr Ul Khaliq; Tajamul Hakeem
Journal:  J Oral Biol Craniofac Res       Date:  2015-12-17

5.  Use of 2-Octyl-Cyanoacrylate in surgical closing of Postparotidectomy salivary fistulas.

Authors:  Zoran Pesic; Nikola Buric; Ivica Vuckovic; Dragan Petrovic; Dragan Krasic; Andrija Cosic; Ivana Djokic
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-09-08       Impact factor: 2.503

Review 6.  BOTOX: Broadening the Horizon of Dentistry.

Authors:  Pranav Nayyar; Pravin Kumar; Pallavi Vashisht Nayyar; Anshdeep Singh
Journal:  J Clin Diagn Res       Date:  2014-12-05

Review 7.  Botulinum toxin therapy: functional silencing of salivary disorders.

Authors:  A Lovato; D A Restivo; G Ottaviano; G Marioni; R Marchese-Ragona
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-04       Impact factor: 2.124

8.  [Radiotherapy : an option for refractory salivary fistulas].

Authors:  H Christiansen; H A Wolff; J Knauth; A Hille; H Vorwerk; C Engelke; R Rödel; R Laskawi
Journal:  HNO       Date:  2009-12       Impact factor: 1.284

9.  Stensen's duct injuries: the role of sialendoscopy and adjuvant botulinum toxin injection.

Authors:  Tomasz Kopeć; Małgorzata Wierzbicka; Witold Szyfter
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2013-01-21       Impact factor: 1.195

10.  Posttraumatic parotid fistula treated with transdermal scopolamine: a case report.

Authors:  Giulio Pagliuca; Salvatore Martellucci; Chiara Rosato; Camilla Gallipoli; Andrea Gallo
Journal:  Case Rep Surg       Date:  2012-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.